Objective: Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine secreted by macrophages. This study is performed to investigate whether serum MIF is correlated with atrial fibrillation (AF).
| Measurements
Fasting venous blood was collected for further study. Serum MIF concentrations were assessed by an enzyme-linked immunosorbent assay kit (R&D Systems, Minneapolis, MN, USA) [sensitivity: 0.068 ng/mL; assay range: 0.2-10 ng/mL; coefficient of variations (CVs) of intraassay: 4.5%-6%; CVs of inter assay: 8.4%-9.4%].
| Statistical analysis
We used Power and sample size calculators to determine the sample size by a level of α of 0.05 and power of 90%). A minimum sample of seven subjects in the AF and control groups are needed. Data normal distribution was analyzed using the Kolmogorov-Smirnov test. The data differences between case and control groups were analyzed by unpaired t test, Chi-square tests, or Mann-Whitney U test. Chi-square tests, one-way ANOVA, or Kruskal-Wallis test were used to compare the data differences between AF subgroups. Logistic regression model was performed to determine the risk factors for AF. The correlation of serum MIF concentrations with left atrial diameter (LAD) was analyzed by Spearman correlation analysis. P value <.05 was statistically significant.
| RESULTS

| Baseline clinical characteristics
AF patients showed higher systolic blood pressure (SBP), diastolic blood pressure (DBP), triglycerides, and LAD, as well as lower highdensity lipoprotein cholesterol (HDL-C) compared with the controls (Table 1) .
| Serum MIF concentrations in AF patients
There were relatively higher serum MIF concentrations in the case group than in the control group (P<.001) ( Table 1 ). Both simple and multivariate logistic regression analysis indicated the correlation of serum MIF concentrations with AF development (Table 2 ). Permanent AF patients had higher serum MIF concentrations than in paroxysmal and persistent AF groups (Table 3 ). Furthermore, significant higher serum MIF concentrations were observed in persistent AF patients compared with paroxysmal AF subjects ( Table 3 ). 
| Serum MIF concentrations with atrial remolding
| DISCUSSION
Obesity is a risk factor for AF. Obesity and structural heart disease independently predicted AF recurrence in a 5-year follow-up study.
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Bariatric surgery group showed a lowered risk of developing AF by 29% compared with the control group. 11 Weight loss by bariatric surgery decreased the risk of AF among severe obesity subjects. 11 Wong et al. 12 reported that abdominal and overall adiposity, as well as epicardial fat were associated with AF development. MIF regulated the differentiation of 3T3-L1 preadipocytes. Knockdown of MIF expression inhibited the adipogenesis in 3T3-L1 cells. 13 Promoter polymorphisms of MIF gene were shown to be associated with obesity. 14 Circulating MIF concentrations were higher in overweight adolescents compared with the controls. 15 In addition, Median plasma MIF concentrations in severely obese subjects were significantly lowered after weight loss.
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It is suggested that MIF plays a role in AF development through the crossroad between obesity.
Inflammation is a clear mechanism of AF development. Highsensitivity C-reactive protein (CRP) was associated with the development of AF in patients presenting with ST elevation myocardial infarction. 17 Treatment with soluble epoxide hydrolase inhibitor significantly reduced atrial Fibrosis, Atrial Fibroblast Activation, and atrial electric remodeling by inhibiting the activation of key inflammatory signaling molecules. 18 MIF was produced by macrophages after the inflammatory stimulation. 4 MIF was involved in the mechanism of induced increased MIF protein and gene levels in a dose-dependent manner in atrium myocytes, which indicates the possible mechanism of MIF in AF development. 23 In addition, our results demonstrated that serum MIF concentrations were correlated with LAD which is a parameter for atrial remolding. This indicates that MIF is involved in the This study has several potential limitations. First, this is a crosssectional study. The results may be confirmed by future longitudinal studies. Second, the sample is relatively small. We may perform this design again in a larger population.
In conclusion, serum MIF concentrations are correlated with the development of AF.
